North American gets FDA approval for breast cancer treatment
14th Nov 2006, 17:27 GMT
North American Scientific Inc. got approval from the Food and Drug Administration to market a high-dose radiation design of its breast cancer treatment, the company said Tuesday.
North American gets FDA approval for breast cancer treatment related news:
- North American Gets Cancer Treatment OK — FDA News News from StratCenter.com
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- Cancer treatment of black women delayed — United Press International - Consumer Health
- Shorter-course Radiation Treatment Safe For Breast Cancer — Health News from Medical News Today
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer — News-Medical News Feed
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- The Evolving Role of Angiogenesis Inhibition in Treatment of Breast Cancer — Medscape Pathology Headlines
- Surgical Biopsy May Reveal Cancer In Women With Rare But Benign Breast Condition — ScienceDaily Headlines
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications — Radiology News from StratCenter.com
- Check out my breasts — The Cancer Blog